Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer

by Esse I. H. Akpo, Irshaad R. Jansen, Edith Maes, Steven Simoens
Published 2017-09-01